Recap: Helius Medical Tech Q2 Earnings

  Helius Medical Tech (NASDAQ:HSDT) reported its Q2 earnings results on Monday, August 15, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

 

Helius Medical Tech (NASDAQ:HSDT) reported its Q2 earnings results on Monday, August 15, 2022 at 04:00 PM.

Here’s what investors need to know about the announcement.

Earnings

Helius Medical Tech beat estimated earnings by 13.39%, reporting an EPS of $-0.97 versus an estimate of $-1.12.

Revenue was up $48 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.02 which was followed by a 8.11% increase in the share price the next day.

Here’s a look at Helius Medical Tech’s past performance:

 

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -1.13 -1.16 -1.75 -1.53
EPS Actual -1.15 -1.31 -2.01 -2.58
Revenue Estimate 160K 100K 80K 90K
Revenue Actual 190K 258K 109K 71K

To track all earnings releases for Helius Medical Tech visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Levi Strauss & Co Reports Better-Than-Expected Q1 Results, Raises FY24 Guidance

The company reported quarterly earnings of 26 cents per share which beat the analyst consensus estimate of 21 cents by 23.81%. Quarterly sales came in at $1.558 billion which beat the analyst consensus estimate of $1.547 billion and is a 7.76% decrease over sales of $1.689 billion the same period last year. Levi Strauss reported total inventories decreased 14% on a dollar basis as of Feb. 25, and direct-to-consumer net revenues increased 7% on a reported basis.

LEVI